retatrutide phase 2 trial results weight loss Experimental drug shows promising in Peptide Series #3 — Retatrutide

C.MaranhoP.BouskelaE.et al (2022)

Moreover, self-administration without professional guidance may lead to improper dosing, raising safety concerns

Coverage at NY Times, front page today and my input to that piece As someone whos studied peptide hormones for 30 years, Id like to know what these peptides are, what receptors they target, at what doses, what are their biological effects, what animal models have verified their effects, and what clinical trials have been conducted with specific outcomes

Your prescribing physician at PlexusDx will review your baseline labs and schedule follow-up testing typically at 48 weeks and then every 36 months, allowing them to track the trajectory of your metabolic improvement